-
BioSig – Medical Device Maker Is Revolutionizing How Arrhythmias Are Treated
Wednesday, September 6, 2023 - 3:39pm | 220Ken Londoner, CEO of BioSig Technologies (NASDAQ: BSGM), was recently a guest on Benzinga’s All-Access BioSig is a digital signal processing company that has created the PURE EP Platform. The company unites expertise in medical engineering, intellectual property and workflow to deliver...
-
NVIDIA Inception Chooses BioSig AI For Innovation In Healthcare AI, An Industry That Is Projected To Reach $272.9 Billion By 2030
Thursday, July 20, 2023 - 9:15am | 531BioSig Technologies, Inc. (NASDAQ: BSGM) is a groundbreaking medical technology company that specializes in providing precision and accuracy in visualizing intracardiac signals. Recently, their subsidiary, BioSig AI Sciences, Inc. (BAIS), was chosen to join NVIDIA Inception. This prestigious...
-
Artificial Intelligence In Healthcare: A Potentially Strong Opportunity For BioSig Technologies (NASDAQ: BSGM)?
Wednesday, July 12, 2023 - 8:12am | 550BioSig Technologies, Inc. (NASDAQ: BSGM) announced a new collaboration agreement in June with Reified Labs, a technical advisory service specializing in advanced artificial intelligence (AI). Together, BioSig and Reified will research and develop an AI medical device platform with the potential to...
-
New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
Wednesday, May 24, 2023 - 8:00am | 954Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ: BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans, LA last week. The platform’s precision signal-capturing technology is meant to improve...
-
MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care
Thursday, April 7, 2022 - 9:10am | 1105This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the...
-
BioSig Technologies Inc. Reports Increased Adoption of its Signal Processing Technology for Arrhythmia Care
Tuesday, November 9, 2021 - 9:07am | 640Photo provided by BioSig The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. BioSig Technologies Inc. (NASDAQ: BSGM), a medical technology company commercializing an innovative signal-...
-
BioSig's PURE EP Aims to Address Unmet Needs of Afib Patients
Thursday, September 23, 2021 - 9:47am | 922The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Image by PublicDomainPictures from Pixabay An estimated 33.5 million individuals worldwide and nearly 2.7 million people in the U.S...
-
BioSig Expands in Electrophysiology with St. Elizabeth's Medical Center Evaluation
Friday, September 17, 2021 - 7:40am | 667The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Increasing its ever-growing presence in the cardiac electrophysiology space, BioSig Technologies (NASDAQ: BSGM) will be installing...
-
Mayo Clinic Purchases BioSig's PURE EP™ for use at its Phoenix Location
Tuesday, July 6, 2021 - 9:44am | 612The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. According to a recently filed 8-k, BioSig Technologies, Inc. (NASDAQ: BSGM) received a new purchase order from the Mayo Foundation for...
-
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
Wednesday, June 30, 2021 - 10:03am | 1074The Company recently increased its procedural volume targets due to accelerated technology usage BioSig expands its commercial team to target technology adoption across three strategic regions Westport, CT, June 30, 2021 /GLOBE NEWSWIRE/ — BioSig Technologies, Inc. (...
-
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
Tuesday, May 4, 2021 - 6:28pm | 925The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians have conducted over 800 arrhythmia patient cases to date Currently conducting patient cases in 9 medical centers across the country including...
-
BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System
Wednesday, December 16, 2020 - 10:45am | 931The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. According to recent information published on WHO's 2019 Global Health Estimates, heart disease remains the leading cause of death...